Pulling the plug on clinical equipoise: a critique of Miller and Weijer

Kennedy Institute of Ethics Journal
Fred Gifford

Abstract

As clinicians, researchers, bioethicists, and members of society, we face a number of moral dilemmas concerning randomized clinical trials. How we manage the starting and stopping of such trials--how we conceptualize what evidence is sufficient for these decisions--has implications for both our obligations to trial participants and for the nature and security of the resultant medical knowledge. One view of how this is to be done, "clinical equipoise," recently has been given an extended defense by Paul Miller and Charles Weijer in their article "Rehabilitating Equipoise." The present paper critiques this position and Miller and Weijer's defense of it. I argue that their attempted rehabilitation fails. Their analysis suffers from a number of confusions, as well as a failure to make crucial distinctions, adequately to clarify key concepts, or to think through exactly what needs to be established to justify their claim. We are left with little reason to uphold the clinical equipoise criterion.

Citations

May 30, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Michael H Kottow
Dec 18, 2013·Birth Defects Research. Part C, Embryo Today : Reviews·Paulo Zielinsky, Stefano Busato
Nov 30, 2007·PLoS Medicine·Gail E HendersonCatherine R Zimmer
Nov 10, 2005·Thoracic Surgery Clinics·Franklin G Miller
May 15, 2010·Journal of Psychoactive Drugs·Frank Y WongS Arayasirikul
Jul 11, 2012·Clinical Trials : Journal of the Society for Clinical Trials·Franklin G Miller
Jan 4, 2012·European Archives of Psychiatry and Clinical Neuroscience·Hanfried Helmchen
Jul 13, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Rieke van der Graaf, Johannes J M van Delden
Jan 26, 2021·Médecine sciences : M/S·Vincent Israel-Jost, Léo Coutellec

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Kennedy Institute of Ethics Journal
Jerry Menikoff
The American Journal of the Medical Sciences
Franklin G Miller
British Journal of Neurosurgery
Adel HelmyPeter Hutchinson
© 2021 Meta ULC. All rights reserved